【24h】

Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.

机译:前庭神经鞘瘤的伽玛刀放射外科:早期听力结果和耳蜗剂量评估。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To evaluate the hearing outcomes for a group of unilateral vestibular schwannoma patients treated with gamma knife radiosurgery and to determine if the cochlear radiation dose affects hearing outcome measures. STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. PATIENTS: Vestibular schwannoma patients (n = 33) treated with gamma knife with complete audiometric follow-up. INTERVENTION: Gamma knife radiosurgery and audiometry. MAIN OUTCOME MEASURES: Pure-tone average (PTA), speech discrimination score (SDS), and cochlear radiation dose. RESULTS: The median audiometric follow-up was 24 months, with a range of 6 to 51 months (mean, 24.6 mo; standard deviation [SD], 13.9). Thirty-one patients received a maximum radiation dose of 26 Gy, and 2 received 24 Gy (mean, 25.9 Gy; SD, 0.48). All patients were treated to the 50% isodose line, and the prescription isodose was 13 Gy in 31 patients and 12 Gy in 2 patients (mean, 12.9 Gy; SD, 0.24). Mean pretreatment PTA and SDS were 55.86 dB and 45.70%, respectively. Mean PTA and SDS at last follow-up were 66.55 dB and 39.15%, respectively. The PTA at 6 months (p = 0.003), 12 months (p = 0.004), and last follow-up (p = 0.001) was significantly poorer than the pretreatment PTA. There was no significant difference between pretreatment and follow-up SDS at any time interval. The mean cochlear radiation dose was 5.2 Gy (range, 2.6-8.5 Gy). The median cochlear dose was 4.75 Gy. Fifteen patients received less than the median cochlear dose, and 18 received greater than or equal to the median cochlear dose. The change in PTA from baseline was significantly poorer at 12 months for those patients whose cochlea received 4.75 Gy (p = 0.02) or greater. Stepwise linear regression analysis using the variables of minimum SDS subsequent to baseline SDS versus total cochlear dose revealed a negative correlation (p = 0.012)-as total cochlear dose increased, SDS decreased. CONCLUSION: The PTA was significantly worse after gamma knife radiosurgery, with a mean follow-up of 24.6 months. Higher radiation doses to the cochlear volume negatively impacted hearing outcomes after radiosurgery for this group of vestibular schwannoma patients.
机译:目的:评估一组接受伽玛刀放射治疗的单侧前庭神经鞘瘤患者的听力结果,并确定耳蜗辐射剂量是否影响听力结果测量。研究设计:回顾性病例审查。地点:第三级转诊中心。患者:前庭神经鞘瘤患者(n = 33)接受伽玛刀治疗,并进行了完全的听觉随访。干预:伽玛刀放射外科和听力测验。主要观察指标:纯音平均(PTA),语音识别分数(SDS)和耳蜗辐射剂量。结果:听力测验的中位随访时间为24个月,范围为6到51个月(平均24.6 mo;标准差[SD] 13.9)。 31位患者的最大放射剂量为26 Gy,2位患者的最大放射剂量为24 Gy(平均25.9 Gy; SD为0.48)。所有患者均接受50%等剂量线治疗,其中31名患者的处方等剂量剂量为13 Gy,2名患者的处方等剂量剂量为12 Gy(平均12.9 Gy; SD为0.24)。预处理的平均PTA和SDS分别为55.86 dB和45.70%。最后一次随访的平均PTA和SDS分别为66.55 dB和39.15%。与治疗前的PTA相比,在6个月(p = 0.003),12个月(p = 0.004)和最后一次随访(p = 0.001)时的PTA明显较差。在任何时间间隔,预处理和后续SDS之间无显着差异。平均耳蜗辐射剂量为5.2 Gy(范围为2.6-8.5 Gy)。中耳蜗剂量为4.75 Gy。 15名患者接受的中耳蜗剂量少于中位数,18名患者接受的中耳蜗剂量大于或等于中位数。对于那些耳蜗接受4.75 Gy(p = 0.02)或更高的患者,PTA从基线的变化在12个月时明显较差。使用基线SDS之后的最小SDS变量与总耳蜗剂量的逐步线性回归分析显示出负相关(p = 0.012)-随着总耳蜗剂量增加,SDS减少。结论:伽玛刀放射治疗后PTA明显恶化,平均随访24.6个月。对于这组前庭神经鞘瘤患者,较高的耳蜗剂量放射剂量对放射治疗后的听力结果产生负面影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号